Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany

PLoS One. 2024 May 9;19(5):e0303776. doi: 10.1371/journal.pone.0303776. eCollection 2024.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0278460.].

Publication types

  • Published Erratum